Pharmaceuticals News

Financing co-led by new investors Bain Capital Life Sciences, Forbion and Novo Holdings, with strong participation from additional new and existing investors  Proceeds to advance MC2 receptor...

Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes The Phase 1 trial will assess the...

Over 80% of assessed basal cell carcinoma lesions regressed across three Gorlin syndrome patients treated with KB113 Substantial regression was observed in lesions not directly injected with KB113,...

                   Providing a Foundational Quality Management System (QMS) for Commercialization Certificate issued by GMED, an EU MDR notified body, following the positive certification decision...

DXS welcomes the announcement from NHS England which has announced plans for a new £838.7m open framework for GP IT solutions

DXS welcomes the announcement from NHS England which has announced plans for a new £838.7m open framework for GP IT solutions

VANCOUVER, British Columbia, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse...

Osivax Reports Phase 2b Results for OVX836 and Advances Combination Strategy for Next-Generation Seasonal Influenza Vaccines

invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journal Publication in Molecular Therapy Oncology reports Phase 1 data from 17 patients with...

iOnctura appoints Paul Sekhri as Chair of its Board of Directors